{"name":"Eluciderm Inc","slug":"eluciderm-inc","ticker":"","exchange":"","domain":"","description":"Eluciderm Inc is a biotechnology company focused on developing innovative topical treatments for dermatological conditions. The company's lead product, ELU42 Topical Spray, is currently in Phase 1 clinical trials.","hq":"","founded":0,"employees":"N/A","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiyAFBVV95cUxQdFloMWZ3NllxSVBaRk1PYVFrYk0wcEpXWm9TZFFsRDAxQnF0bHZxWjZSaE9CSHgzUG93S2M4WGtCSk55WUUwUVJNb1RSMFpuNnVoTTNZYVJGa1RvY3pFcU8tdm50dzM3dndhbVJxdmRrVW5QZnpVeE9rVDhYS0RkYmdzekpiZjdjSVhpMTdjZnYzTHBTUlBjT0VHaVQxQ291NFVlTlZMeEVBOGRZVkVBTHQzMkdiUjVDQmI0RmFFX25ZRExnX0RDTA?oc=5","date":"2025-07-08","type":"regulatory","source":"Business Wire","summary":"Eluciderm, Inc. Announces U.S. FDA Clearance of IND Application for ELU42 - Business Wire","headline":"Eluciderm, Inc. Announces U.S. FDA Clearance of IND Application for ELU42","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxNbUgzQXpCOU5hU20wN1dwYmxZMjZGQkZCNm5MRWRkVWdZbUhkaS01WjN2OGpXT01YeTVlX3FoWGlQNFNaTjZjcXgyZi1HbzNCSlpyOUh0WFVzMTJZcm5lQ04wWUdOS1c4NjhlaDVFeFV4UUxfTUlEbEJ6OGVZUl9YU19ScHNVWjkzOENib2Etc3BwQVZFZ09ZZWlGeE5OcTlrN3Z4cXgzc0NCaW5xMXZmRWRPdUY?oc=5","date":"2024-06-22","type":"pipeline","source":"Business Wire","summary":"Eluciderm, Inc. Wins WHS Wound Shark 2024 Innovation Award - Business Wire","headline":"Eluciderm, Inc. Wins WHS Wound Shark 2024 Innovation Award","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}